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Abstract
Background: First reemerged malaria case was reported in 1993 after two decades absent in South Korea.
Thereafter, Plasmodium vivax spreads out near demilitarized zone (DMZ). This study investigated the prevalence of
P. vivax after the malaria transmission season in Gimpo-si where adjacent to DMZ of South Korea. An indirect
fluorescent antibody test (IFAT) was performed to evaluate anti-malaria antibodies in blood samples.
Methods: Microscopic examinations were performed to identify the presence of malaria parasites. Antibodies
against P. vivax were detected using IFAT, and blood samples from antibody-positive cases were tested using a
polymerase chain reaction (PCR) assay that detects malaria parasites.
Results: A total of 5,797 blood samples were collected from residents in Gimpo-si. The positivity rate by IFAT was
2.16% (n = 125). Yangchon-myeon (3.28%) had the highest positivity rate of the seven administrative districts
tested. Positivity rates increased with age (P < 0.05). Sixteen of the IFAT positive samples (12.80%, n = 125) were
positive for malaria DNA according to PCR. Blood samples with an antibody titer over 1:256 had high positivity
rates in the PCR analysis (P < 0.05).
Conclusions: These results indicate that antibody titers obtained using IFAT may provide useful information about
the prevalence of P. vivax in low endemic areas and could be used to detect asymptomatic patients. Finding
asymptomatic patients is important in eliminating vivax malaria in South Korea.
Background
Plasmodium vivax, a causative agent of relapsing benign
tertian human malaria, is the second- most important
human malaria and afflicts several hundred million peo-
ple annually. This disease is a major public health pro-
blem, with associated socioeconomic ramifications, for
many temperate and most tropical countries [1].
For several centuries, vivax malaria has been prevalent
throughout the Korean peninsula. The first scientific doc-
umentation of malaria was published in 1913. At that
time, malaria occurred throughout the country without
noticeable geographical distinctions [2]. However, the
incidence of vivax malaria has rapidly decreased [3,4] due
to a national malaria eradication program and help from
the World Health Organization (WHO). Vivax malaria
was believed to have been eradicated in South Korea in
the late 1970s, although two sporadic cases were detected
in the 1980s. These two patients relapsed after a long
incubation period [5]. In 1993, a soldier in the South
Korea army serving in northern Gyeonggi-do was diag-
nosed with vivax malaria [6]. Subsequently, Cho et al
reported two civilian patients infected with vivax malaria
[7]. Thereafter, a total of 2,198 vivax malaria patients
were detected between 1994 and 1997 near the demilitar-
ized zone (DMZ), centering around the villages of Paju-si,
Yeoncheon-gun, Cheorwon-gun, Gimpo-si, Ganghwa-
gun, Goyang-si, and Dongducheon-si. There is a great
concerned that this re-emergence may lead to the
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[8]. The north-western region of Gyeonggi-do has been
ecologically preserved because people are not allowed in
the DMZ [9]. These factors raise the possibility that vivax
malaria has been reintroduced and that there is active
local transmission.
T h er a i n ys e a s o nu s u a l l yb e g i n si nl a t eJ u n ea n d
extends through the end of July. In South Korea, the
potential vectors of vivax malaria are Anopheles sinensis,
Anopheles kleini,a n dAnopheles pullus. Malaria trans-
mission is expected to begin 3-4 weeks after the appear-
ance of vector mosquitoes in mid-May. An. sinensis
(63.3%) was the most abundant anopheline mosquito
captured in malaria high-risk areas (northern Gyeonggi-
do) near the DMZ in South Korea, followed by An.
kleini (24.7%) and An. pullus (8.7%) [10]. The incidence
of malaria peaks in August after the rainy season and
declines to baseline levels during mid-October. There-
fore, blood collection was carried out between late
October and mid-December, when the anopheline popu-
lation disappears.
Gimpo-si is located in north-western South Korea
a n di ss u r r o u n d e db yt h eI m j i nR i v e ra n dt h eH a n
River, which are close to North Korea. The Korean
National Institute of Health (KNIH) reported one case
of malaria in 1995, one in 1996, 15 in 1997, and 65 in
1998. These cases led the malaria research team at the
KNIH to investigate the prevalence of malaria in
Gimpo-si using microscopy and indirect fluorescent
antibody tests (IFATs). Seroimmunological diagnosis,
in particular by IFAT, is an important tool for the
detection of malaria, especially when microscopic evi-
dence of the parasites is not a v a i l a b l ed u et ot h es e v -
eral reasons [11-14]. Blood samples were collected
from 845 residents in this area from November to
December 1998. Twenty-four residents were seroposi-
tive for malaria by IFAT. Four seropositive residents
(16.7%) developed symptoms of malaria in the follow-
ing year. Based on the results from these preliminary
trials, there is ample evidence to suggest that there are
asymptomatic malaria patients in this area. In this
study, the significant role that IFAT plays in identify-
ing asymptomatic patients and providing information
on the prevalence of malaria is demonstrated.
Methods
Study areas and blood sample collection
The study was conducted in Gimpo-si, Gyeonggi-do,
South Korea, from late October to mid- December
1999. All participants were adult volunteers who were
enrolled after the nature of the study was explained and
verbal informed consent was obtained. Approximately
3 ml of blood was collected from each individual. Thin
and thick blood smears were prepared for microscopic
examination (magnification 7 × 100). The blood samples
were transferred to the KNIH, Korea Centers for Dis-
ease Control and Prevention (KCDC), where the sera
and blood were separated and stored at -20°C for future
antibody and polymerase chain reaction (PCR) analyses.
The study protocol was reviewed and approved by the
Human Ethics Committee of the KNIH.
Indirect fluorescent antibody test
To test for antibodies against malaria, an IFAT was per-
formed with whole blood antigen against P. vivax
[15-17]. Briefly, 10 ml of malaria parasite-infected blood
was collected by venipuncture from P. vivax indigenous
patients. After removing the plasma, the cells were sus-
pended in phosphate-buffered saline (PBS, pH 7.2) and
centrifuged for 5 min at 2,500 rpm. The supernatant
was discarded, and the cells were resuspended in fresh
P B S .T h ew a s hs t e pw a sr e p e a t e dt h r e em o r et i m e s .
Finally, an appropriate amount of PBS was added to
maintain the parasitemia at no less than 1%. Cells were
added to each well of Teflon coated slides. After being
dried at room temperature for 12 hrs, the slides were
stored at -70°C. To determine the antibody titers against
P. vivax for each patient, the antigen slides were fixed in
pre-cooled acetone (-20 °C) for 10 min and washed with
PBS; then 20 μl of 1:32 to 1:8,192 (vol/vol) was diluted
sera was added to each well. Positive and negative con-
trols were spotted onto each slide and incubated in a
humidified chamber for 30 min at 37°C. The reactions
were stopped by washing the reacted sera with PBS. The
slides were immersed in PBS for 6 min and then dried
at room temperature. Diluted FITC-conjugated anti-
human IgG (Sigma, 1:32 vol/vol in PBS) was added to
each well, incubated, and washed using the same
method described above. Several drops of buffered gly-
cerol were added to the samples, and the slides were
covered with coverslips. The slides were examined
under a 40× objective of a fluorescence microscope.
Polymerase chain reaction (PCR)
Genomic DNA was extracted from the blood samples
using a QIAamp Blood Kit (Qiagen). PCR was per-
formed with AccuPower PCR Premix (Bioneer), 50 ng
of purified genomic DNA, and 40 pmol each of each
forward (MSP-F; 5’-ACCATGTGTATAGACACCAATG
TGCCTGATAATGCA-3’) and reverse (MSP-R; 5’-
TTAAAGCTCCATGCACAGGAGGAAAAGCAA-3’)
primer to amplify interspecies conserved block 10
(ICB10). The final volume was adjusted to 20 μlw i t h
distilled water. The cycling conditions were as follows:
(1) denaturation at 94°C for 5 min, (2) 40 cycles of
1 min at 94°C, 1 min at 62°C, and 1 min at 72°C, and
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were analysed on a 1.2% agarose gel and viewed on a
UV transilluminator.
Calculation of the annual parasite index (API)
The annual parasite index (API) was calculated as the
incidence of malaria per 1,000 residents.
Data analysis
Relationships between antibody titer and PCR-positivity
rate, positive rates of IFAT and age groups, and dates of
blood collection and PCR-positive cases were analysed
by correlation. Analysis of the annual parasite index
(API) was carried out using Kruskal-Wallis test. Rela-
tionship between APIs and IFAT positivity rates of vil-
lages were analysed by Two-way ANOVA. Data analyses
were performed using GraphPad (GraphPad Software,
Inc., La Jolla, CA).
Results
Blood collection
T h el o c a t i o no ft h es t u d ya r e ai ss h o w no nt h ea c c o m -
panying map. Four villages, Gimpo 1-dong, Gimpo
2-dong, Sau-dong, and Pungmu-dong, are adjacent to
each other and are collectively considered as Gimpo-
dongs, resulting in seven sites located on the map
(Figure 1). All samples were collected from seven vil-
lages located in Gimpo-si, Gyeonggi-do, South Korea. In
this area, a mean of 3.92% of residents per village were
sampled. A total of 5,797 blood samples were collected
from the 148,066 inhabitants of Gimpo-si in 1999.
Among the blood samples, 2,423 were collected from
males, and 3,374 were from females, resulting in a
1:1.39 sex ratio. The mean age was 48.78 years (range 2
to 97 years).
Positivity rate of IFAT
T h ec r i t e r i af o rap o s i t i v eI F A Tr e s u l tw e r ee s t a b l i s h e d
in a previous experiment. Briefly, when 86 individuals
and 58 vivax malaria patients were tested, normal indivi-
duals had a serum dilution under 1:16 (range from 0 to
1:16), and the 58 vivax malaria patients had a serum
dilution over 1:256 (range from 1:256 to 1:4096). There-
fore, a positive antibody response was defined against
vivax malaria as a serum dilution above (≥ )1:32 [22].
A total of 125 samples from 5,797 people (2.16%) were
Figure 1 Study areas. I, Gochon-eup; II, Gimpo-dongs (Gimpo 1-dong, Gimpo 2-dong, Sau-dong, and Pungmu-dong); III, Yangchon-myeon; IV,
Daegot-myeon; V, Tongjin-myeon; VI; Wolgot-myeon; and VII, Haseong-myeon. ( ) indicates the positivity rate of IFAT.
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positivity rate at 3.28% (9/274, API: 1.23), followed by
Wolgot-myeon (2.61%, 29/1,109, API: 2.90), Tongjin-
myeon (2.42%, 25/1,034, API: 0.71), Haseong-myeon
(2.42%, 25/1,033, API: 2.15), Daegot-myeon (2.29%, 19/
830, API: 0.52), Gochon-eup (1.90, 8/422, API: 0.34),
and Gimpo-dongs (0.91%, 10/1,095, API: 0.14). The vil-
lages located in the northern part of Gimpo-si, closest
to the DMZ had a higher positivity rate than those in
the southern part (Table 1). Two-way ANOVA test
showed significant between APIs and IFAT positive
rates of villages (P < 0.05).
The highest positivity rate according to age group was
80-89 years (5/162, 3.09%, API: 5.62), followed by 70-79
years (19/638, 2.98%, API: 2.39). The lower positivity
groups were 10-19 (7/604, 1.16%, API: 0.16), 20-29 (5/
389, 1.29%, API: 0.43), 30-39 (11/784, 1.40%, API: 0.33),
and 90-99 years (0/3, 0%, API: 0). These results indicate
that the positivity rate of IFAT increased with age
groups (P = 0.03), furthermore similar result was
observed in API analysis (P = 0.003) (Table 2). Positivity
rate (2.23%) of males is higher than the positivity rate
(2.10%) of females (Table 3).
Relationship between PCR positive and antibody positive
None of the cases were positive according to microscopic
examination. Therefore, genomic DNA was prepared
from 125 antibody positive blood samples for PCR analy-
sis with MSP-1 specific primers. Sixteen of the 125
(12.80%) antibody-positive cases were positive by PCR.
Eight PCR-positive cases had an antibody titer of 1:32,
four had a titer of 1:64, one had a titer of 1:256, one had
a titer of 1:512, one had a titer of 1;1024, and one had a
titer of 1:2048 (Figure 2A). The PCR positivity rate
increased as the antibody titer increased (Figure 2B, P <
0.05). It showed a significant reduction of PCR-positive
cases according to the dates of blood collection (P =
0.0013). Four PCR-positive cases were detected at first
date of blood collection (26
th Oct, day 0), 5 cases at sec-
ond date (27
th Oct, day 2), and no case at the end of
blood collection (12
th Dec, day 47). PCR-positive cases
were detected until mid-November. After that time, no
additional positive cases were found. Eleven PCR-positive
cases (68.75%) were collected in October, and 5 cases
(31.25%) were collected in November (Figure 3). All sero-
positive persons were free of clinical signs or symptoms
of malaria at the time of sample collection.
Analysis of annual parasite index (API) in Gimpo-si during
1997-2006
Annual parasitic index (API) of Gimpo-si showed 0.54 ±
0.29 during ten years (from 1997 to 2006) after reemerging
vivax malaria in Gimpo-si. Among them, Wolgot-myeon
(1.61 ± 0.93) showed highest API, Haseong-myeon (1.42 ±
0.65) ranked second. These areas are closed to DMZ.
Yangchon-myeon (0.62 ± 0.36) ranked third. Gochon-
myeon (0.19 ± 0.16) and Gimpo-dongs (0.16 ± 0.07) have
a lower APIs than other areas. These areas located far
from DMZ among seven study areas (Figure 4, P <
0.0001). APIs were increased by age groups. Age group 0-
9 showed API as 0.06 ± 0.04, age group 10-19 as 0.41 ±
0.31, age group 20-29 as 0.57 ± 0.37, age group 30-39 as
0.81 ± 0.67, age group 40-49 as 0.96 ± 0.74, age group 50-
59 as 0.95 ± 0.61, age group 60-69 as 0.84 ± 0.46, age
group 70-79 as 0.99 ± 0.83 (Figure 5, P <0 . 0 5 ) .
Discussion
The outbreak areas of re-emerging malaria in South
Korea were mostly limited to Paju-si and Yeoncheon-
gun, Gyeonggi-do, which are located within 10-15 km of
Table 1 Positivity rate and distribution of fluorescent antibody responses of sera according to area
Village No. of Sera
Tested
No. of
Positive Sera
aIFAT serum dilution endpoint Positivity rate
(%)
bAPI
< 1:32 ≥ 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048
Gochon-eup 422 8 414 3 4 1 0 0 0 0 1.90 0.34
Gimpo-dongs 1095 10 1085 7 1 1 1 0 0 0 0.91 0.14
Yangchon-
myeon
274 9 265 8 0 1 0 0 0 0 3.28 1.23
Daegot-myeon 830 19 811 12 5 1 0 1 0 0 2.29 0.52
Tongjin-myeon 1034 25 1019 9 12 2 0 2 0 0 2.42 0.71
Wolgot-myeon 1109 29 1080 10 9 3 3 2 1 1 2.61 2.90
Haseong-
myeon
1033 25 1008 14 6 4 0 1 0 0 2.42 2.15
Total 5797 125 5672 63 37 13 4 6 1 1 2.16 0.68
Note.
aIFAT; Indirect fluorescent antibody test.
bAPI; Annual parasite index from 1999.
*Significant between API and IFAT positive rate was analysed by Two-way ANOVA (P < 0.05).
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wide and 250-km-long corridor that extends across the
middle part of the Korean peninsula. No civilians have
been allowed to enter into the DMZ for more than
50 years; therefore, the natural landscape ecosystems
and biodiversity are highly conserved in the DMZ [9].
Each year, outbreak areas are expanding to both the
south and east from DMZ and are believed to have ori-
ginated from the northern part of the DMZ. Re-emer-
ging malaria is presumed to have originated not from
the immigration of infected people from the north but
from mosquitoes infected with P. vivax that flew from
the north because passage through the DMZ is almost
impossible. The corridor is heavily fortified on both
sides of the buffer zones with land mines and barbed
wire fences [23-26].
In July and August 1997, two 15-year-old patients
were reported to have indigenous vivax malaria in
Gimpo-si, Gyoenggi-do. The patients were teammates
on a football team at Tongjin Middle School, which is
located in the north-western part of Gimpo-si, approxi-
mately 8.5 km south of the DMZ. They had no history
of travelling abroad or abusing drugs [27]. A malaria
team from the KNIH investigated whether vivax malaria
could become prevalent in Gimpo-si in the near future.
This study used IFAT because serological data can pro-
vide useful evidence for the extent and degree of malaria
endemicity [11], especially in areas with low endemicity
[13]. The rate of parasitaemia is the classical method for
measuring the endemicity of malaria, whereas the inci-
dence of parasitaemia alone may fail to fully provide an
adequate description of the prevalence of malaria in a
population. When the incidence of malaria is low, mass
blood surveys do not yield results that are commensu-
rate with the amount of work involved [28]. Therefore,
the application of IFAT may reflect the prevalence of
malaria in population [14].
Previously, it was observed that 16.67% (4/24) of sero-
positive cases exhibited malaria symptoms in the follow-
ing year (authors’ unpublished data). This observation
suggests that some seropositive cases may be asympto-
matic. Those seropositive residents that did not exhibit
malaria symptoms have a history of exposure to malaria
parasites. It is not clear how many seropositive cases are
asymptomatic. During the winter season, malaria para-
sites can survive mainly but not all in the liver as hyp-
nozoites in human. Parasites cannot survive for long
periods of time in human blood due to the host
immune system; therefore, they reside in the liver,
which allows the parasites to evade the immune system.
Table 2 Positivity rate and distribution of fluorescent antibody responses of sera according to age
Age No. of Sera Tested No. of Positive Sera
aIFAT serum dilution endpoint Positivity rate (%)
bAPI
< 1:32 ≥ 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048
0 - 9 299 7 292 3 4 0 0 0 0 0 2.34 0
10 - 19 604 7 597 4 3 0 0 0 0 0 1.16 0.16
20 - 29 389 5 384 2 1 0 1 1 0 0 1.29 0.43
30 - 39 784 11 773 6 4 1 0 0 0 0 1.40 0.33
40 - 49 842 23 819 10 8 3 0 2 0 0 2.73 1.04
50 - 59 912 19 893 8 8 3 0 0 0 0 2.08 1.69
60 - 69 1164 29 1135 18 5 2 1 3 0 0 2.49 1.68
70 - 79 638 19 619 11 4 2 2 0 0 0 2.98 2.39
80 - 89 162 5 157 1 0 2 0 0 1 1 3.09 5.62
90 - 99 3 0 3 0 0 0 0 0 0 0 0 0
Total 5797 125 5672 63 37 13 4 6 1 1 2.16 0.68
Note.
aIFAT; Indirect fluorescent antibody test.
bAPI; Annual parasite index from 1999.
*It shows significant correlation between age group and IFAT positivity rate of IFAT (P = 0.03) (except age group 90-99).
§It shows significant correlation between age group and API (P = 0.003) (except age group 90-99).
Table 3 Positivity rate and distribution of fluorescent antibody responses of sera according to sex
Sex No. of Sera Tested No. of Positive Sera *IFAT serum dilution endpoint Positivity rate (%)
<1:32 ≥ 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048
Male 2418 54 2364 26 17 5 3 2 1 0 2.23
Female 3379 71 3308 37 20 8 1 4 0 1 2.10
Total 5797 125 5672 63 37 13 4 6 1 1 2.16
Note. *IFAT; Indirect fluorescent antibody test.
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ined the malaria status of 1,000 soldiers who served in
high-risk areas, and four soldiers (0.4%) were shown to
be infected with the parasite by nested PCR. They had
no clinical signs or symptoms associated with P. vivax
although one of the soldiers showed symptoms after a
few weeks. These results indicate asymptomactic cases
are present in the Korean population. Out of 1,713 sol-
diers who served in high-risk areas during P. vivax
transmission season, 15% had antibodies for Pv200, mer-
ozoite surface protein-1 (MSP-1). Eleven of the 40 sol-
diers who later developed symptomatic malaria had
elevated levels of anti-Pv200 antibody up to three
months prior to the onset of symptoms. This result
indicates that the P. vivax blood stage antigen may have
increased during the early erythrocytic stage of infection,
which indicates that the antibody test could be used in
seroepidemiologic studies as an efficient tool for moni-
toring the prevalence of malaria in large cohorts. Con-
sidering the challenges in detecting malaria due to its
long incubation period and the sometimes mild sympto-
matology of Korean P. vivax, anti-Pv200 ELISA and
Figure 2 Relationship between PCR-positive and IFAT-positive cases. A, Number of PCR- positive cases according to antibody titer. B,
Proportion of asymptomatic patients according to antibody titer.
Figure 3 PCR positive cases according to their collection date.
Figure 4 Annual parasite index (API) according to areas from
1997 to 2006. These values were calculated as the incidence of
malaria per 1,000 residents.
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systematically eradicate malaria from Korea [29].
Based on the findings mentioned above, the preva-
lence of malaria was investigated in a low endemicity
area (Gimpo-si). 5,797 blood samples were collected
from residents of Gimpo-si in 1999. 125 seropositive
cases were detected, 12.80% (16 cases) of which were
also positive by PCR. These results indicate that the
antibody level titers obtained by IFAT may increase the
likelihood of identifying asymptomatic patients. This
technique will be helpful in the early eradication of
malaria in Korea. Additional studies should be examine
the relationship between antibody titer and PCR results,
specifically whether high antibody titers obtained by
IFAT increase the chances of finding PCR positive
cases, as shown in Figure 2 (P < 0.05). PCR-positive
cases were correlated with the pattern of the incidence
of malaria. Patient cases were reported from March to
November, with a peak in August [23,24], because any
PCR- positive cases did not identify in December (Figure
3). The Yangchon-myeon showed the highest positivity
rate (3.28%) by IFAT. This village is located in the mid-
dle of Gimpo-si and is surrounded by large rice fields.
This environmental might provide a good habitat for
malaria vectors. However, the annual parasite index
(API) for Yangchon-myeon ranked third among the 7
villages (Table 1). As shown in Table 1 and Figure 4,
the positivity rate of IFAT represents the API of each
village. The positivity rate was relatively higher for the
over-30 age group than under-30 age group (P <0 . 0 5 ) .
Additionally, the positivity results for IFAT were similar
to the API for 1999 (Table 2, P <0 . 0 5 ) .I na d d i t i o n ,t h e
APIs from 1997 to 2006 supported the observation that
the positivity rate for IFAT increased with age (Figure 5,
P < 0.05). During malaria transmission season, adults of
this age often work from early in the morning to late at
night in the fields without protection from mosquitoes.
Children in the under-9 ageg r o u ps h o w e dah i g hp o s i -
tivity rate (2.34%). The children are most likely to be
exposed to malaria vectors with their parents during
evening activities. However, the 10 to 39 age group
showed a relatively low positivity rate; students and
business workers normally belong to this age group.
Therefore, this age group would be exposed less than
other age groups to malaria vectors due to their life-
styles (Table 2). The positivity rate of males was higher
than that of females. Malesm a yh a v em o r eo u t d o o r
activities than females (Table 3).
Conclusions
The main finding from this study was that antibody
detection using IFAT might provide information about
the prevalence of malaria in certain areas. Thus, this
information might help us to understand the prevalence
of malaria in the past and in the future situations. Addi-
tionally, IFAT might provide useful information about
P. vivax malaria infections in epidemic areas and could
be useful in diagnosing asymptomatic patients. It is
important to find asymptomatic patients to eliminate
vivax malaria, and the addition of a serological method
to normal surveillance methods can increase the accu-
racy of the interpretation about the prevalence of
malaria.
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